Zydus Lifesciences Ltd on Tuesday said it has ... products include Zituvio (sitagliptin), Zituvimet (sitagliptin and metformin hydrochloride) and Zituvimet XR (sitagliptin and metformin ...
The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...
Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...
The date of expiry of patent protection for empagliflozin is March 10, 2025. Retail prices for empagliflozin and metformin hydrochloride formulations were approved for Zydus Healthcare Ltd, Alkem ...